Bausch + Lomb gives up on glaucoma eye drop hopeful after phase 2 fail Read more 

Fierce Biotech Fundraising Tracker '26: MindRank rakes in $52M to advance phase 3-stage oral GLP-1 Read more 

ARPA-H awards up to $160M to scientists developing custom genetic medicines Read more 

Max Eldridge

Max has more than ten years in Life Sciences recruitment, He collaborates with executives to foster growth in Pharma, Biotech, CRO, TechBio, and Medical Device sectors​

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2026 | Hlx Life Sciences

Go to Top